Abacavir and lamivudine tablets are a generic version of GlaxoSmithKline’s Epzicom tablets. Epzicom tablets reported annual sales of about $449 million in the U.S. as of July 2016, according to IMS data.
At present, Teva has more than 300 products pending approval from the FDA.
More articles on supply chain:
US businesses’ most pressing supply chain concerns: 4 things to know
8 latest FDA approvals
Why EpiPens are so much cheaper in Europe
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
